Fujita T, Takata S, Sunahara Y
Biochemical Research and Development Center, Oriental Yeast Co., Ltd., Osaka, Japan.
Clin Chem. 1993 Oct;39(10):2130-6.
A two-step method for assaying creatinine in serum and urine samples, suitable with automated analyzers, is reported. Reagent 1, for the first step, contains a blanking system [creatine amidinohydrolase (CRTase), urease, glutamate dehydrogenase, NADPH, and 2-oxoglutarate] and a NADPH-regenerating system [Mg(2+)-dependent isocitrate dehydrogenase (ICD), MgCl2, and excess isocitrate]. Reagent 2, for the second step, contains the metal-chelating reagent trans-1,2-cyclohexanediamine-N,N,N',N'-tetraacetic acid (CyDTA) and a trigger system [creatinine amidohydrolase (CRNase)]. When a specimen is mixed with reagent 1, all the creatine, urea, and NH3 present are removed by the blanking and NADPH systems. On adding reagent 2, CyDTA inactivates ICD to inhibit the NADPH system. Simultaneously, the creatinine (1 mol) in the specimen is hydrolyzed into creatine by CRNase, and then releases NADP+ (2 mol) through the blanking system. Our optimized method can determine creatinine linearly up to 500 mg/L, with within-day CVs < 1.2% and day-to-day CVs < 2.7%.
本文报道了一种适用于自动分析仪的血清和尿液样本中肌酐检测的两步法。第一步的试剂1包含一个空白系统[肌酸脒基水解酶(CRTase)、脲酶、谷氨酸脱氢酶、NADPH和2-氧代戊二酸]以及一个NADPH再生系统[Mg(2+)-依赖的异柠檬酸脱氢酶(ICD)、MgCl2和过量的异柠檬酸]。第二步的试剂2包含金属螯合剂反式-1,2-环己二胺-N,N,N',N'-四乙酸(CyDTA)和一个触发系统[肌酐酰胺水解酶(CRNase)]。当样本与试剂1混合时,所有存在的肌酸、尿素和NH3会被空白系统和NADPH系统去除。加入试剂2时,CyDTA会使ICD失活以抑制NADPH系统。同时,样本中的肌酐(1摩尔)会被CRNase水解为肌酸,然后通过空白系统释放出NADP+(2摩尔)。我们优化后的方法可线性测定肌酐,上限为500 mg/L,日内变异系数<1.2%,日间变异系数<2.7%。